FrancophonIA/ELRC3.0 huggingface dataset:
English: Ensure that needle with needle guard is firmly attached to the syringe by pushing while turning the needle guard.
Slovenian: Prepričajte se, da je igla z zaščitnim pokrovčkom trdno pritrjena na brizgo.
English: Collect necessary items before you begin: - a vial of IntronA solution for injection; - a syringe with an attached needle for subcutaneous injection; - a cleansing swab.
Slovenian: Priprava Preden začnete, si pripravite vse potrebne pripomočke: vialo zdravila IntronA raztopina za injiciranje, brizgo za subkutano injiciranje s pritrjeno iglo, čistilni tampon.
English: 25 million IU/2.5 mL solution for injection or infusion 1 multiple dose vial
Slovenian: 25 milijonov i.e./2,5 ml raztopina za injiciranje ali infundiranje 1 viala z večkratnimi odmerki
English: Therefore, the combination of IntronA with telbivudine is contraindicated.
Slovenian: Ti učinki so lahko tudi resnejši, zato je uporaba kombinacije zdravila IntronA in telbivudina kontraindicirana.
English: Rotate the needle protection device for bevel orientation or scale readability.
Slovenian: Pripomoček za zaščito igle obrnite v poševen položaj oziroma tako, da lahko vidite merilno skalo.
English: IntronA 10 million IU/mL solution for injection or infusion
Slovenian: IntronA 10 milijonov i.e./ml raztopina za injiciranje ali infundiranje
English: Be sure to seek emergency care if you notice that you are becoming depressed or have suicidal thoughts or change in your behaviour.
Slovenian: Če opazite, da postajate depresivni ali imate samomorilne misli oz. se je vaše obnašanje spremenilo, morate poiskati nujno medicinsko pomoč.
English: IntronA (3 MIU TIW) + ribavirin (800 mg)
Slovenian: trikrat na teden) + ribavirin (800 mg)
English: IntronA plus ribavirin
Slovenian: Zdravilo IntronA in ribavirin
English: Cardiomyopathy, that may be reversible upon discontinuation of interferon alpha, has been reported rarely in patients without prior evidence of cardiac disease (see section 4.4).
Slovenian: V redkih primerih so pri bolnikih, ki prej niso imeli nikakršnih znakov srčne bolezni, poročali o kardiomiopatiji, ki je po ukinitvi interferona alfa lahko reverzibilna (glejte poglavje 4.4).
English: IntronA 25 million IU/2.5 mL solution for injection or infusion
Slovenian: IntronA 25 milijonov i.e./2,5 ml raztopina za injiciranje ali infundiranje
English: Some people get depressed when taking IntronA alone or in combination treatment with ribavirin, and in some cases people had thoughts about threatening the life of others, suicidal thoughts or aggressive behaviour (sometimes directed against others).
Slovenian: V nekaterih primerih so se pri bolnikih pojavile misli, kako ogroziti življenje drugih, samomorilne misli ali agresivno obnašanje (včasih usmerjeno proti drugim), nekaj bolnikov pa je dejansko naredilo samomor.
English: Table 5 Sustained virological response in previously untreated children and adolescents IntronA 3 MIU/m2 3 times a week ribavirin 15 mg/kg/day
Slovenian: IntronA 3 mio i.e./m2 3-krat na teden ribavirin 15 mg/kg/dan
English: Conjunctivitis, vision abnormal, lacrimal gland disorder, eye pain
Slovenian: konjunktivitis, boleče oči, motnje vida, bolezni solzne žleze
English: Pure red cell aplasia, idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura
Slovenian: levkopenija trombocitopenija, limfadenopatija, limfopenija aplastična anemija čista aplazija eritrocitov, idiopatska trombocitopenična purpura, trombotična trombocitopenična purpura
English: Hairy Cell Leukaemia: 2 million IU/m 2, 3 times a week (every other day) injected subcutaneously (under the skin).
Slovenian: Dlakastocelična levkemija: 2 milijona i.e./m 2, 3-krat na teden (vsak drugi dan) s subkutano (podkožno)
English: One vial contains 25 million IU of interferon alfa-2b in 2.5 mL of solution.
Slovenian: Ena viala vsebuje 25 milijonov i.e. interferona alfa-2b v 2,5 ml raztopine.
English: IntronA 5 million IU/0.5 mL solution for injection or infusion
Slovenian: IntronA 5 milijonov i.e./0,5 ml raztopina za injiciranje ali infundiranje
English: In addition, injection site disorders, pyrexia, anorexia, vomiting, and emotional lability occurred more frequently in children and adolescents compared to adult patients.
Slovenian: Poleg tega so se pri otrocih in mladostnikih pogosteje kot pri odraslih bolnikih pojavile težave na mestu injiciranja, zvišana telesna temperatura, anoreksija, bruhanje in čustvena labilnost.
English: Collect necessary items before you begin: - a vial of IntronA solution for injection; - a syringe (for example 2 mL); - a needle for the subcutaneous injection (for example 0.4 x 13 mm [27 gauge 0.5 inch]); - a cleansing swab.
Slovenian: Priprava Preden začnete, si pripravite vse potrebne pripomočke: vialo zdravila IntronA raztopina za injiciranje, brizgo (npr. 2-mililitrsko), iglo za subkutano injiciranje (npr. 0,4  13 mm), čistilni tampon.
English: For example, in a trial of high-dose adjuvant IntronA treatment in patients with melanoma, incidences of fatigue, pyrexia, myalgia, neutropaenia/anaemia, anorexia, nausea and vomiting, diarrhoea, chills, flulike symptoms, depression, alopecia, altered taste, and dizziness were greater than in the hepatitis C trials.
Slovenian: Na primer, v raziskavi adjuvantne terapije z velikimi odmerki zdravila IntronA pri bolnikih z melanomom so bile pojavnosti utrujenosti, zvišane telesne temperature, mialgije, nevtropenije oz. anemije, anoreksije, navzeje in bruhanja, driske, mrzlice, gripi podobni simptomov, depresije, alopecije, sprememb okusa in omotice večje kot v raziskavah hepatitisa C. Tudi njihova jakost se je pri terapiji z velikimi odmerki povečala (stopnja 3 po WHO pri 66 % bolnikov in stopnja 4 po WHO pri 14 % bolnikov) v primerjavi z blago do zmerno jakostjo, ki se običajno pojavlja pri manjših odmerkih.
English: Each vial contains 5 million IU in 0.5 mL of solution.
Slovenian: Ena viala vsebuje 5 milijonov i.e. v 0,5 ml raztopine.
English: SVR after treatment of chronic HCV with non-pegylated interferon alfa-2b (with or without ribavirin) results in long-term clearance of the virus providing resolution of the hepatic infection and clinical 'cure' from chronic HCV.
Slovenian: Trajni virološki odziv po zdravljenju kronične okužbe z virusom hepatitisa C z nepegiliranim interferonom alfa-2b (z ali brez ribavirina) vodi do dolgotrajnega očistka virusa ter tako odpravi jetrno okužbo in omogoči klinično »ozdravitev« kronične okužbe z virusom hepatitisa C. To pa ne pomeni, da ne bo prišlo do jetrnih dogodkov pri bolnikih s cirozo (vključno s hepatokarcinomom).
English: Alopecia, pruritus*, skin dry*, rash*, sweating increased Psoriasis (new or aggravated)
Slovenian: alopecija, pruritus*, suha koža*, izpuščaj*, povečano potenje psoriaza (nov pojav ali poslabšanje obstoječe) makulopapulozni izpuščaj, eritematozni izpuščaj, ekcem, eritem, kožna bolezen
English: EU/1/99/127/029 2 multiple dose vials
Slovenian: EU/1/99/127/029 2 viali z večkratnimi odmerki
English: p value
Slovenian: vrednost
English: IntronA (3 MIU TIW) + ribavirin
Slovenian: trikrat na teden) + ribavirin
English: IntronA 3 million IU/0.5 mL solution for injection or infusion
Slovenian: IntronA 3 milijone i.e./0,5 ml raztopina za injiciranje ali infundiranje
English: Discontinue treatment with IntronA in patients with chronic hepatitis who develop prolongation of coagulation markers which might indicate liver decomposition.
Slovenian: Pri bolnikih s kroničnim hepatitisom, pri katerih se pojavi podaljšanje parametrov koagulacije, ki bi lahko kazalo na jetrno dekompenzacijo, prekinite terapijo z zdravilom IntronA.
English: (affects 1 to 10 users in 100) Uncommon (affects 1 to 10 users in 1,000) Rare
Slovenian: (pojavijo se pri 1 do 10 bolnikih od 1.000 bolnikov)
English: 10 million IU/mL solution for injection or infusion 1 single dose vial
Slovenian: 10 milijonov i.e./ml raztopina za injiciranje ali infundiranje 1 viala z enkratnim odmerkom
English: One vial contains 5 million IU of interferon alfa-2b in 0.5 mL of solution.
Slovenian: Ena viala vsebuje 5 milijonov i.e. interferona alfa-2b v 0,5 ml raztopine.
English: 2 years.
Slovenian: 4 tednov.
English: One vial of solution for injection or infusion contains 18 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 3 mL of solution.
Slovenian: Ena viala raztopine za injiciranje ali infundiranje vsebuje 18 milijonov i.e. rekombinantnega interferona alfa-2b, pridobljenega iz E. coli s tehnologijo rekombinantne DNA, v 3 ml raztopine.
English: Collect necessary items before you begin: - a vial of IntronA solution for injection; - a syringe (for example 1 mL); - a needle for the subcutaneous injection (for example 0.4 x 13 mm [27 gauge 0.5 inch]); - a cleansing swab.
Slovenian: Priprava Preden začnete, si pripravite vse potrebne pripomočke: vialo zdravila IntronA raztopina za injiciranje, brizgo (npr. 1-mililitrsko), iglo za subkutano injiciranje (npr. 0,4  13 mm), čistilni tampon.
English: 3 mL of solution (corresponding to 18 MIU) is contained in a multidose vial (type I glass) with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene).
Slovenian: 3 ml raztopine (kar ustreza 18 milijonom i.e.) je v viali z več odmerki (iz stekla tipa I), z zamaškom (iz halobutilne gume) in zaporko s ploščico (iz aluminija) s pokrovčkom (iz polipropilena).
English: 5 million IU/0.5 mL solution for injection or infusion 1 single dose vial
Slovenian: 5 milijonov i.e./0,5 ml raztopina za injiciranje ali infundiranje 1 viala z enkratnim odmerkom
English: One vial contains 3 million IU of interferon alfa-2b in 0.5 mL of solution.
Slovenian: Ena viala vsebuje 3 milijone i.e. interferona alfa-2b v 0,5 ml raztopine.
English: Therefore, check with your doctor or pharmacist about drinking alcoholic beverages, or taking sleeping pills, sedatives or strong pain medicines.
Slovenian: Zdravilo IntronA okrepi učinke drugih snovi, ki upočasnijo živčni sistem in lahko povzročijo zaspanost, zato se posvetujte z zdravnikom ali farmacevtom glede pitja alkoholnih pijač ali jemanja uspaval, pomirjeval ali močnih analgetikov.
English: The development of auto-antibodies and autoimmune disorders has been reported during treatment with alpha interferons.
Slovenian: Med zdravljenjem z alfa interferoni so poročali o pojavu avtoprotiteles in avtoimunih bolezni.
English: Prompt discontinuation of interferon alpha administration and treatment with corticosteroids appear to be associated with resolution of pulmonary adverse events.
Slovenian: Kaže, da pljučni neželeni učinki minejo ob takojšnji ukinitvi interferona alfa in zdravljenju s kortikosteroidi.
English: Each vial contains 3 million IU in 0.5 mL of solution.
Slovenian: Ena viala vsebuje 3 milijone i.e. v 0,5 ml raztopine.
English: Uncommon: Very rarely:
Slovenian: Občasni: Zelo redki:
English: Ocular adverse events (see section 4.8) including retinal haemorrhages, cotton wool spots, serous retinal detachment, and retinal artery or vein obstruction have been reported in rare instances after treatment with alpha interferons.
Slovenian: V redkih primerih so po zdravljenju z alfa interferoni poročali o očesnih neželenih učinkih (glejte poglavje 4.8), npr. krvavitvah v mrežnico, belih ali rumenih lisah na površini mrežnice (cotton wool spots), seroznem odstopu mrežnice in zamašitvi mrežnične arterije ali vene.
English: Multiple myeloma: 3 million IU/m 2, 3 times a week (every other day) injected subcutaneously (under the skin).
Slovenian: Multipli mielom: 3 milijoni i.e./m 2 3-krat na teden (vsak drugi dan) s subkutano (podkožno) injekcijo.
English: Patients co-infected with HIV and receiving Highly Active Anti-Retroviral Therapy (HAART) may be at increased risk of developing lactic acidosis.
Slovenian: Pri bolnikih, ki so sočasno okuženi z virusom HIV in prejemajo visoko aktivno protivirusno terapijo (Highly Active Anti-Retroviral Therapy - HAART), je lahko tveganje za nastanek laktacidoze povečano, zato svetujemo previdnost pri dodatku zdravila IntronA in ribavirina terapiji HAART (glejte SPC za ribavirin).
English: 3 million IU/0.5 mL solution for injection or infusion 1 single dose vial
Slovenian: 3 milijoni i.e./0,5 ml raztopina za injiciranje ali infundiranje 1 viala z enkratnim odmerkom
English: Dental and gum disorders, which may lead to loss of teeth, have been reported in patients receiving IntronA and ribavirin combination therapy.
Slovenian: Pri bolnikih, ki so prejemali zdravilo IntronA in ribavirin v kombinirani terapiji, so poročali o boleznih zob in obzobnih tkiv, ki lahko vodijo do izgube zob.
English: IntronA is supplied as: - Pack of 1 vial - Pack of 1 vial, 6 injection syringes of 1 mL, 6 injection needles and 12 cleansing swabs - Pack of 1 vial, 6 injection syringes with attached needle and needle protection device of 1 mL
Slovenian: Zdravilo IntronA je na voljo v naslednjih pakiranjih: - 1 viala - 1 viala, 6 (1-mililitrskih) injekcijskih brizg, 6 injekcijskih igel in 12 čistilnih tamponov - 1 viala, 6 (1-mililitrskih) injekcijskih brizg s pritrjeno iglo ter pripomočkom za zaščito igle in
English: §, rash maculopapular, rash erythematous, eczema, erythema, skin disorder Stevens Johnson syndrome, toxic epidermal necrolysis, erythema multiforme
Slovenian: Stevens-Johnsonov sindrom, toksična epidermalna nekroliza, multiformni eritem
English: IntronA 18 million IU/3 mL solution for injection or infusion Interferon alfa-2b
Slovenian: IntronA 18 milijonov i.e./3 ml raztopina za injiciranje ali infundiranje interferon alfa-2b
English: Auto-antibodies and autoimmune disorders
Slovenian: Avtoprotitelesa in avtoimune bolezni
English: 1 mL of solution (corresponding to 10 MIU) is contained in a single dose vial (type I glass) with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene).
Slovenian: 1 ml raztopine (kar ustreza 10 milijonom i.e.) je v viali z enkratnim odmerkom (iz stekla tipa I), z zamaškom (iz halobutilne gume) in zaporko s ploščico (iz aluminija) s pokrovčkom (iz polipropilena).
English: One vial of solution for injection or infusion contains 10 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 1 mL of solution.
Slovenian: Ena viala raztopine za injiciranje ali infundiranje vsebuje 10 milijonov i.e. rekombinantnega interferona alfa-2b, pridobljenega iz E. coli s tehnologijo rekombinantne DNA, v 1 ml raztopine.
English: Maintenance treatment: 10 million IU/m 2, 3 times a week (every other day) injected subcutaneously (under the skin).
Slovenian: Vzdrževalno zdravljenje: 10 milijonov i.e./m 2 3-krat na teden (vsak drugi dan) s subkutano
English: EU/1/99/127/019 1 single dose vial
Slovenian: EU/1/99/127/019 1 viala z enkratnim odmerkom
English: Injection site inflammation, injection site reaction, fatigue, rigors, pyrexia
Slovenian: vnetje na mestu injiciranja, reakcija na mestu injiciranja, utrujenost, mrzlica, zvišana telesna temperatura
English: - One mL of solution contains 6 million IU of interferon alfa-2b.
Slovenian: - En ml raztopine vsebuje 6 milijonov i.e. interferona alfa-2b.
English: One vial of solution for injection or infusion contains 25 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 2.5 mL of solution.
Slovenian: Ena viala raztopine za injiciranje ali infundiranje vsebuje 25 milijonov i.e. rekombinantnega interferona alfa-2b, pridobljenega iz E. coli s tehnologijo rekombinantne DNA, v 2,5 ml raztopine.
English: EU/1/99/127/015 1 single dose vial
Slovenian: EU/1/99/127/015 1 viala z enkratnim odmerkom
English: Pack of 2 vials, 12 injection syringes with attached needle of 1 mL and 24 cleansing swabs Pack of 12 vials
Slovenian: 2 viali, 12 (1-mililitrskih) injekcijskih brizg s pritrjeno iglo in 24 čistilnih tamponov 12 vial
English: EU/1/99/127/011 1 single dose vial
Slovenian: EU/1/99/127/011 1 viala z enkratnim odmerkom
English: 2.5 mL of solution (corresponding to 25 MIU) is contained in a multidose vial (type I glass) with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene).
Slovenian: 2,5 ml raztopine (kar ustreza 25 milijonom i.e.) je v viali z več odmerki (iz stekla tipa I), z zamaškom (iz halobutilne gume) in zaporko s ploščico (iz aluminija) s pokrovčkom (iz polipropilena).
English: EU/1/99/127/030 12 multiple dose vials
Slovenian: EU/1/99/127/030 12 vial z večkratnimi odmerki
English: EU/1/99/127/023 1 multiple dose vial
Slovenian: EU/1/99/127/023 1 viala z večkratnimi odmerki
English: Caution must be exercised when administering IntronA in combination with other potentially myelosuppressive agents.
Slovenian: Pri sočasni uporabi zdravila IntronA in drugih potencialno mielosupresivnih učinkovin je potrebna previdnost.
English: One mL of solution contains 6 million IU of interferon alfa-2b.
Slovenian: En ml raztopine vsebuje 6 milijonov i.e. interferona alfa-2b.
English: Injection site inflammation, injection site reaction*, fatigue, rigors, pyrexia
Slovenian: vnetje na mestu injiciranja, reakcija na mestu injiciranja*, utrujenost, mrzlica, zvišana telesna temperatura
English: Pack of 1 vial, 6 injection syringes of 1 mL, 6 injection needles and 12 cleansing swabs Pack of 1 vial, 6 injection syringes with attached needle and needle protection device of 1 mL and 12 cleansing swabs
Slovenian: 1 viala, 6 (1-mililitrskih) injekcijskih brizg, 6 injekcijskih igel in 12 čistilnih tamponov 1 viala, 6 (1-mililitrskih) injekcijskih brizg s pritrjeno iglo ter pripomočkom za zaščito igle in 12 čistilnih tamponov
English: Epistaxis, respiratory disorder, nasal congestion, rhinorrhea, cough nonproductive Pulmonary infiltrates
Slovenian: dispneja*, kašelj* epistaksa, bolezni dihal, zamašen nos, izcedek iz nosu, neproduktiven kašelj pljučni infiltrati
English: 0.5 mL of solution (corresponding to 5 MIU) is contained in a single dose vial (type I glass) with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene).
Slovenian: 0,5 ml raztopine (kar ustreza 5 milijonom i.e.) je v viali z enkratnim odmerkom (iz stekla tipa I), z zamaškom (iz halobutilne gume) in zaporko s ploščico (iz aluminija) s pokrovčkom (iz polipropilena).
English: - One mL of solution contains 10 million IU of interferon alfa-2b
Slovenian: En ml raztopine vsebuje 10 milijonov i.e. interferona alfa-2b
English: How to store IntronA
Slovenian: Shranjevanje zdravila IntronA
English: IntronA 10 million IU/mL solution for injection or infusion Interferon alfa-2b
Slovenian: IntronA 10 milijonov i.e./ml raztopina za injiciranje ali infundiranje interferon alfa-2b
English: One vial of solution for injection or infusion contains 3 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 0.5 mL of solution.
Slovenian: Ena viala raztopine za injiciranje ali infundiranje vsebuje 3 milijone i.e. rekombinantnega interferona alfa-2b, pridobljenega iz E. coli s tehnologijo rekombinantne DNA, v 0,5 ml raztopine.
English: IntronA contains less than 1 mmol sodium (23 mg) per 2.5 mL, i.e., essentially "sodium-free".
Slovenian: Zdravilo IntronA vsebuje manj kot 1 mmol (23 mg) natrija na 2,5 ml, kar v bistvu pomeni "brez natrija".
English: IntronA contains less than 1 mmol sodium (23 mg) per 0.5 mL, i.e., essentially "sodium-free".
Slovenian: Zdravilo IntronA vsebuje manj kot 1 mmol (23 mg) natrija na 0,5 ml, kar v bistvu pomeni "brez natrija".
English: One vial of solution for injection or infusion contains 5 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 0.5 mL of solution.
Slovenian: Ena viala raztopine za injiciranje ali infundiranje vsebuje 5 milijonov i.e. rekombinantnega interferona alfa-2b, pridobljenega iz E. coli s tehnologijo rekombinantne DNA, v 0,5 ml raztopine.
English: Pack of 1 vial, 1 injection syringe of 1 mL, 1 injection needle and 1 cleansing swab Pack of 6 vials, 6 injection syringes of 1 mL, 6 injection needles and 6 cleansing swabs Pack of 12 vials, 12 injection syringes of 1 mL, 12 injection needles and 12 cleansing swabs Not all pack sizes may be marketed.
Slovenian: - 1 viala, 1 (1-mililitrska) injekcijska brizga, 1 injekcijska igla in 1 čistilni tampon - 6 vial, 6 (1-mililitrskih) injekcijskih brizg, 6 injekcijskih igel in 6 čistilnih tamponov - 12 vial, 12 (1-mililitrskih) injekcijskih brizg, 12 injekcijskih igel in 12 čistilnih tamponov Na trgu morda ni vseh navedenih pakiranj.
English: Flushing, pallor
Slovenian: Nalepka, viala
English: Disodium phosphate anhydrous Sodium dihydrogen phosphate monohydrate Edetate disodium
Slovenian: - Pomožne snovi so brezvodni natrijev hidrogenfosfat, natrijev dihidrogen fosfat monohidrat,
English: 0.5 mL of solution (corresponding to 3 MIU) is contained in a single dose vial (type I glass) with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene).
Slovenian: 0,5 ml raztopine (kar ustreza 3 milijonom i.e.) je v viali z enkratnim odmerkom (iz stekla tipa I), z zamaškom (iz halobutilne gume) in zaporko s ploščico (iz aluminija) s pokrovčkom (iz polipropilena).
English: EU/1/99/127/047 12 multiple dose vial, 72 injection syringes with attached needle and needle protection device of 1 mL and 144 cleansing swabs
Slovenian: EU/1/99/127/047 12 vial z večkratnimi odmerki, 72 (1-mililitrskih) injekcijskih brizg s pritrjeno iglo ter pripomočkom za zaščito igle in 144 čistilnih tamponov
English: Pack of 1 vial, 6 injection syringes with attached needle of 1 mL and 12 cleansing swabs Pack of 2 vials
Slovenian: 1 viala, 6 (1-mililitrskih) injekcijskih brizg s pritrjeno iglo in 12 čistilnih tamponov 2 viali
English: 12 multiple dose vials, 72 injection syringes of 1 mL, 72 injection needles and 144 cleansing swabs 12 multiple dose vial, 72 injection syringes with attached needle and needle protection device of 1 mL and 144 cleansing swabs
Slovenian: 12 vial, 72 (1-mililitrskih) injekcijskih brizg, 72 injekcijskih igel in 144 čistilnih tamponov 12 vial, 72 (1-mililitrskih) injekcijskih brizg s pritrjeno iglo ter pripomočkom za zaščito igle in 144 čistilnih tamponov
English: and 24 cleansing swabs - Pack of 12 vials - Pack of 12 vials, 72 injection syringes of 1 mL, 72 injection needles and 144 cleansing swabs - Pack of 12 vials, 72 injection syringes with attached needle and needle protection device of
Slovenian: 24 čistilnih tamponov - 12 vial - 12 vial, 72 (1-mililitrskih) injekcijskih brizg, 72 injekcijskih igel in 144 čistilnih tamponov - 12 vial, 72 (1-mililitrskih) injekcijskih brizg s pritrjeno iglo ter pripomočkom za zaščito igle in
English: IntronA 25 million IU/2.5 mL solution for injection or infusion Interferon alfa-2b
Slovenian: IntronA 25 milijonov i.e./2,5 ml raztopina za injiciranje ali infundiranje interferon alfa-2b
English: IntronA contains less than 1 mmol sodium (23 mg) per 1 mL, i.e., essentially "sodium-free".
Slovenian: Zdravilo IntronA vsebuje manj kot 1 mmol (23 mg) natrija na 1 ml, kar v bistvu pomeni "brez natrija".
English: EU/1/99/127/042 12 multiple dose vials, 72 injection syringes of 1 mL, 72 injection needles and 144 cleansing swabs
Slovenian: EU/1/99/127/042 12 vial z večkratnimi odmerki, 72 (1-mililitrskih) injekcijskih brizg, 72 injekcijskih igel in 144 čistilnih tamponov
English: 12 multiple dose vial, 72 injection syringes with attached needle of 1 mL and 144 cleansing swabs
Slovenian: 12 vial z večkratnimi odmerki, 72 (1-mililitrskih) injekcijskih brizg s pritrjeno iglo in 144 čistilnih tamponov
English: and 12 cleansing swabs - Pack of 2 vials - Pack of 2 vials, 12 injection syringes of 1 mL, 12 injection needles and 24 cleansing swabs - Pack of 2 vials, 12 injection syringes with attached needle and needle protection device of 1 mL
Slovenian: 12 čistilnih tamponov - 2 viali - 2 viali, 12 (1-mililitrskih) injekcijskih brizg, 12 injekcijskih igel in 24 čistilnih tamponov - 2 viali, 12 (1-mililitrskih) injekcijskih brizg s pritrjeno iglo ter pripomočkom za zaščito igle in
English: EU/1/99/127/027 1 multiple dose vial
Slovenian: EU/1/99/127/027 1 viala z večkratnimi odmerki